Risk factors for radiation-induced lung toxicity in patients with non-small cell lung cancer who received postoperative radiation therapy

被引:25
作者
Zhao, Lujun [1 ,2 ,3 ]
Ji, Wei [1 ,2 ]
Ou, Guangfei [1 ,2 ]
Lv, Jima [1 ,2 ]
Liang, Jun [1 ,2 ]
Feng, Qinfu [1 ,2 ]
Zhou, Zongmei [1 ,2 ]
Wang, Luhua [1 ,2 ]
Yin, Weibo [1 ,2 ]
机构
[1] Peking Union Med Coll, Dept Radiat Oncol, Canc Hosp, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Beijing 100021, Peoples R China
[3] Tianjin Med Univ, Canc Inst & Hosp, Dept Radiat Oncol, Tianjin 300060, Peoples R China
关键词
Non-small-cell lung cancer; Surgery; Radiation therapy; Chemotherapy; Radiation-induced lung toxicity; Prognosis; END RESULTS DATABASE; RESECTED STAGE-II; RANDOMIZED-TRIAL; THORACIC RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; PNEUMONITIS; DEATH; EPIDEMIOLOGY; SURVEILLANCE; IRRADIATION;
D O I
10.1016/j.lungcan.2012.03.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background and purpose: To evaluate the risk factors for radiation-induced lung toxicity (RILT) from postoperative radiation therapy (PORT) in patients with non-small cell lung cancer (NSCLC). Material and methods: Ninety NSCLC patients who received PORT with or without chemotherapy from November 2002 to March 2006 were retrospectively analyzed. Each individual's radiotherapy plans were reviewed to determine the percentage of the whole lung volume that received more than a specific dose of irradiation (V-dose). The endpoint was RILT of grade 2 or higher. Data of potential risk factors for RILT were extracted from the medical records and evaluated by logistic regression modeling, the t-test, and the Chi-square test. Results: A total of 20 patients received pneumonectomy, while the remaining 70 received lobectomy. In the lobectomy group, 9 patients (10%) developed >= grade 2 RILT. Among the clinical factors, only adjuvant chemotherapy was significantly correlated with RILT (p = 0.039). For lung dosimetric factors, V-20 through V-40 were all significantly higher in the RILT group than in the non-RILT group. In the lobectomy group, the incidence of RILT was 27.3% in patients who received adjuvant chemotherapy and whose V-20 was greater than 20%. It was 9.7% in lobectomy patients with one of the risk factors, and 0.0% in those with no risk factors (p = 0.032). Conclusions: The lung toxicity of PORT was found to be acceptably low. Adjuvant chemotherapy and lung dosimetric factors of V-20-V-40 were significantly correlated with RILT risk in NSCLC patients. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:326 / 330
页数:5
相关论文
共 26 条
[1]
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data [J].
Auperin, A. ;
Le Chevalier, T. ;
Le Pechoux, C. ;
Pignon, J. P. ;
Tribodet, H. ;
Burdett, S. ;
Stewart, L. A. ;
Tierney, J. F. ;
Stephens, R. J. ;
Arriagada, R. ;
Higgins, J. P. ;
Johnson, D. H. ;
van Meerbeeck, J. ;
Parmar, M. K. B. ;
Souhami, R. L. ;
Bergman, B. ;
Dautzenberg, B. ;
Douillard, J. Y. ;
Dunant, A. ;
Endo, C. ;
Girling, D. J. ;
Imaizumi, M. ;
Kato, H. ;
Keller, S. M. ;
Kimura, H. ;
Knuuttila, A. ;
Kodama, K. ;
Komaki, R. ;
Kris, M. G. ;
Lad, T. ;
Mineo, T. ;
Park, J. H. ;
Piantadosi, S. ;
Pyrhonen, S. ;
Rosell, R. ;
Scagliotti, G. V. ;
Seymour, L. W. ;
Shepherd, F. A. ;
Spiro, S. G. ;
Strauss, G. M. ;
Sylvester, R. ;
Tada, H. ;
Tanaka, F. ;
Torri, V. ;
Wada, H. ;
Waller, D. ;
Xu, G. C. .
LANCET, 2010, 375 (9722) :1267-1277
[2]
DOSE-VOLUME ANALYSIS OF RADIATION PNEUMONITIS IN NON-SMALL-CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CISPLATINUM AND ETOPOSIDE WITH OR WITHOUT CONSOLIDATION DOCETAXEL [J].
Barriger, R. Bryan ;
Fakiris, Achilles J. ;
Hanna, Nasser ;
Yu, Menggang ;
Mantravadi, Prasad ;
McGarry, Ronald C. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (05) :1381-1386
[3]
Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: Promising long-term results of the radiation therapy oncology group - RTOG 9705 [J].
Bradley, JD ;
Paulus, R ;
Graham, MV ;
Ettinger, DS ;
Johnstone, DW ;
Pilepich, MV ;
Machtay, M ;
Komaki, R ;
Atkins, J ;
Curran, WJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3480-3487
[4]
Non-small cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation [J].
Das, Amit K. ;
Sato, Mitsuo ;
Story, Michael D. ;
Peyton, Michael ;
Graves, Robert ;
Redpath, Stella ;
Girard, Luc ;
Gazdar, Adi F. ;
Shay, Jerry W. ;
Minna, John D. ;
Nirodi, Chaitanya S. .
CANCER RESEARCH, 2006, 66 (19) :9601-9608
[5]
Predicting lung radiotherapy-induced pneumonitis using a model combining parametric lyman probit with nonparametric decision trees [J].
Das, Shiva K. ;
Zhou, Sumin ;
Zhang, Junan ;
Yin, Fang-Fang ;
Dewhirst, Mark W. ;
Marks, Lawrence B. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (04) :1212-1221
[6]
Dautzenberg B, 1999, CANCER-AM CANCER SOC, V86, P265, DOI 10.1002/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO
[7]
2-B
[8]
Impact of postoperative radiation therapy on survival in patients with complete resection and Stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) randomized trial [J].
Douillard, Jean-Yves ;
Rosell, Rafael ;
De Lena, Mario ;
Riggi, Marcello ;
Hurteloup, Patrick ;
Mahe, Marc-Andre .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03) :695-701
[9]
A study of postoperative radiotherapy in patients with non-small-cell lung cancer: A randomized trial [J].
Feng, QF ;
Wang, M ;
Wang, LJ ;
Yang, ZY ;
Zhang, YG ;
Zhang, DW ;
Yin, WB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :925-929
[10]
Heart irradiation as a risk factor for radiation pneumonitis [J].
Huang, Ellen X. ;
Hope, Andrew J. ;
Lindsay, Patricia E. ;
Trovo, Marco ;
El Naqa, Issam ;
Deasy, Joseph O. ;
Bradley, Jeffrey D. .
ACTA ONCOLOGICA, 2011, 50 (01) :51-60